Lantern Pharma demonstrates AI tools for rare cancers at Jan 22 event

Lantern Pharma Inc.

Event hosted on Jan 22, 2026 to showcase initial AI tools and multi-agentic system for rare cancers.
Presentation furnished as Exhibit 99.1; no financial results or clinical data disclosed.
Company discusses AI-driven drug development platform, but no specific milestones or partnerships announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.